DEA rule seeks to make e-prescriptions more appealing to providers

05/3/2010 | Government Health IT magazine

A new Drug Enforcement Agency rule set to take effect next month could spur health IT adoption among providers by eliminating the requirement that they still use a paper-based system for controlled substances. Under the new rule, they will be allowed to use e-prescriptions for controlled substances. "Physicians will adopt e-prescribing much more rapidly when there is a singular work flow -- whether it's Lipitor or Valium," said Dr. John Halamka, Beth Israel Deaconess Medical Center CIO and Health IT Standards Committee co-chairman.

View Full Article in:

Government Health IT magazine

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN